Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q3

6523.TEDINET S100SW3M
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥256.7bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥89.9bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥265.1bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥94.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income−¥5.1bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income−¥9.3bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥21.4bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥10.9bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax−¥13.8bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥10.7bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥7.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥4.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)−¥11.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.7bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.2bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income−¥11.2bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income−¥8.7bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥2.2bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥541.0bnat 2023-12-31Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥569.9bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥416.7bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥124.3bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥138.8bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥124.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥137.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥43.9bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥59.4bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥28.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥17.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥11.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥31.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥32.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-88.72023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-69.072023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥27.332022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.692022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-88.72023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-69.072023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥27.072022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.532022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio23.0%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31¥1.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥7.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-12-31¥80.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-12-31¥80.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-12-31¥8.8bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-12-31¥79.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-12-31¥79.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-12-31¥4.9bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-12-31¥95.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-12-31¥95.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥11.6bn
—segment totalrevenue2023-04-01 → 2023-12-31¥254.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥254.9bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31¥1.8bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥13.0bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥83.7bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥83.7bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.7bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-12-31¥80.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-12-31¥80.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-12-31¥99.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-12-31¥99.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.5bn
—segment totalrevenue2022-04-01 → 2022-12-31¥263.3bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥263.3bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥34.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 875
ItemContextValueUnit
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration-42000000JPY
Operating profit loss IFRSPrior1QuarterDuration10888000000JPY
Operating profit loss IFRSCurrentQuarterDuration-9310000000JPY
Finance income IFRSPrior1QuarterDuration35000000JPY
Finance income IFRSCurrentQuarterDuration89000000JPY
Finance costs IFRSPrior1QuarterDuration6905000000JPY
Finance costs IFRSCurrentQuarterDuration1527000000JPY
Profit loss before tax IFRSPrior1QuarterDuration4019000000JPY
Profit loss before tax IFRSCurrentQuarterDuration-10748000000JPY
Income tax expense IFRSPrior1QuarterDuration1846000000JPY
Income tax expense IFRSCurrentQuarterDuration-2004000000JPY
Profit loss IFRSPrior1QuarterDuration2172000000JPY
Profit loss IFRSCurrentQuarterDuration-8743000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration2208000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration-8697000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration-36000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration-46000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration17.69
Basic earnings loss per share IFRSCurrentQuarterDuration-69.07
Diluted earnings loss per share IFRSPrior1QuarterDuration17.53
Diluted earnings loss per share IFRSCurrentQuarterDuration-69.07
Profit loss IFRSPrior1YTDDuration3612000000JPY
Profit loss IFRSCurrentYTDDuration-11159000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration822000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-238000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-61000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-1098000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration125000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration67000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration6747000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration9892000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration293000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-348000000JPY
Other comprehensive income IFRSPrior1YTDDuration7927000000JPY
Other comprehensive income IFRSCurrentYTDDuration8273000000JPY
Comprehensive income IFRSPrior1YTDDuration11539000000JPY
Comprehensive income IFRSCurrentYTDDuration-2885000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration11291000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration-2928000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration248000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration43000000JPY
Comprehensive income IFRSPrior1YTDDuration11539000000JPY
Comprehensive income IFRSCurrentYTDDuration-2885000000JPY
Profit loss IFRSPrior1QuarterDuration2172000000JPY
Profit loss IFRSCurrentQuarterDuration-8743000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration9000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-536000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-162000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-680000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1QuarterDuration46000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass